Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
for Advanced Solid Tumor
7 locations incl. Tucson
Sponsor: Vaxiion Therapeutics
Sex: All·Age: 18+
Code: NCT05901285·Phase 1·Recruiting